← Back to Patent Explorer
US4381291A Expired / Lapsed US ⏱️ 0.0 years remaining

Measurement of free ligands

Assignee: Fortia AB
•
Filing: 1980-02-21
•
Granted: 1983-04-26
•
Expires: 2000-02-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for indirect measurement of the concentration of a free ligand in a liquid sample also containing the ligand bound to endogenous binding material, comprising the steps of performing two separate measurements, wherein the first measurement is used to determine the total concentration of free and reversibly bound ligand in the sample to be tested, and the second measurement comprises the steps of (i) exposing separately to a known amount of a labelled ligand (a) the sample to be tested, and (b) each of a plurality of standard solutions containing known concentrations of the free ligand, (ii) thereafter exposing each resulting mixture from (i) (a) and (i) (b) separately to an immobilized binding agent to bind a portion of the free labelled ligand and a similar proportion of the free unlabelled ligand to the immobilized binding agent in each mixture, (iii) separating the immobilized binding agent with its bound ligand from the residual material in each mixture, (iv) measuring the proportion of labelled ligand bound to the immobilized binding agent in each mixture, (v) computing, from this proportion and the total concentration of free and reversibly bound ligand determined in the first measurement, the total amount of ligand bound to the immobilized binding agent in each case, and (vi) estimating from this figure the concentration of free ligand in the sample to be tested using as calibration the known concentrations in the standard solutions.

Inventors

  • 👤 Roger P. Ekins

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 14:00
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/74; G01N33/78; G01N33/53; G01N33/543; G01N33/54306

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 233 words
A method for indirect measurement of the concentration of a free ligand in a liquid sample also containing the ligand bound to endogenous binding material, comprising the steps of performing two separate measurements, wherein the first measurement is used to determine the total concentration of free and reversibly bound ligand in the sample to be tested, and the second measurement comprises the steps: (i) exposing separately to a known amount of labelled ligand (a) the sample to be tested, and (b) each of a plurality of standard solutions containing known concentrations of the free ligand, (ii) thereafter exposing each resulting mixture from (i) (a) and (i) (b) separately to an immobilized binding agent to bind a proportion of the free labelled ligand and a similar proportion of the free unlabelled ligand to the immobilized binding agent in each mixture, (iii) separating the immobilized binding agent with its bound ligand from the residual material in each mixture, (iv) measuring the proportion of labelled ligand bound to the immobilized binding agent in each mixture, (v) computing, from this proportion and the total concentration of free and reversibly bound ligand determined in the first measurement, the total amount of ligand bound to the immobilized binding agent in each case, and (vi) estimating from this figure the concentration of free ligand in the sample to be tested using as calibration the known concentrations in the standard solutions.
Claim 2
Independent Claim 233 words
A method for indirect measurement of the concentration of a free ligand in a liquid sample also containing the ligand bound to endogenous binding material, comprising the steps of performing two separate measurements, wherein the first measurement is used to determine the total concentration of free and reversibly bound ligand in the sample to be tested, and the second measurement comprises the steps: (i) exposing separately to a known amount of labelled ligand (a) the sample to be tested, and (b) each of a plurality of standard solutions containing known concentrations of the free ligand, (ii) thereafter exposing each resulting mixture from (i) (a) and (i) (b) separately to an immobilized binding agent to bind a proportion of the free labelled ligand and a similar proportion of the free unlabelled ligand to the immobilized binding agent in each mixture, (iii) separating the immobilized binding agent with its bound ligand from the residual material in each mixture, (iv) measuring the proportion of labelled ligand bound to the immobilized binding agent in each mixture, (v) computing, from this proportion and the total concentration of free and reversibly bound ligand determined in the first measurement, the total amount of ligand bound to the immobilized binding agent in each case, and (vi) estimating from this figure the concentration of free ligand in the sample to be tested using as calibration the known concentrations in the standard solutions.
Claim 3
Dependent Claim 142 words
A method as claimed in claim 1 wherein the total concentration of free and reversibly bound ligand in the sample to be tested is measured by exposing separately the sample to be tested and each standard solution to a known amount of labelled ligand in the presence of a blocking agent for the reversibly bound ligand, thereafter exposing each resulting mixture separately to immobilised binding agent to bind a proportion of the free labelled ligand and a similar proportion of the free unlabelled ligand to the immobilised binding agent, separating the immobilised binding agent with its bound ligand from the residual material, measuring the proportion of labelled ligand bound to the immobilised binding agent and estimating from this the concentration of free and reversibly bound ligand in the sample to be tested using as calibration the known concentrations in the standard solutions.
Claim 4
Dependent Claim 20 words
A method as claimed in claim 1 wherein the blocking agent is 8-anilino-1-naphthalenesulphonic acid and the ligand is thyroid hormone.
Claim 5
Dependent Claim 39 words
A method as claimed in claim 1 wherein the sample to be tested is derived from a body fluid of a living creature and the ligand is a compound naturally occurring in free and endogenously-bound form in that fluid.
Claim 6
Dependent Claim 35 words
A method as claimed in claim 1 wherein the sample to be tested is derived from a body fluid of a human patient and the ligand is a thyroid hormone selected from thyroxine and triiodothyronine.

References Cited (Backward Citations)

US4166102A Cited
US4052504A Cited
GB1522566A Cited
US4108975A Cited
DE2806860A1 Cited
US4225574A Cited
FR2396795A1 Cited
BE878687A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-04-25 1986-10-25 1987-04-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-04-25 1990-10-25 1991-04-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-04-25 1994-10-25 1995-04-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag